Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0E9NU
|
|||
| Former ID |
DIB012450
|
|||
| Drug Name |
KRN-23
|
|||
| Synonyms |
Human mAb (injectable formulation, hypophosphatemia) Kyowa Hakko
Click to Show/Hide
|
|||
| Indication | Hypophosphatasia [ICD-11: 5C64.3; ICD-10: E83.3] | Phase 3 | [1] | |
| X-linked hypophosphataemia [ICD-11: 5C63.22] | Phase 3 | [2] | ||
| Company |
Kyowa Hakko Kirin Co Ltd
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02526160) Study of KRN23 in Adults With X-linked Hypophosphatemia (XLH). | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.